Completed NCT05841030
This study is completed in the United States, in France, in Canada, .... It focuses on depression.
Depression Other From 18 Years to 74 Years
Countries United States, France, Canada, ...
Sponsor Janssen Research & Development, LLC
Condition Depression Active Not Recruiting NCT03642964
This study is active but not recruiting. It focuses on depression and currently lists study information in the United States.
Depression Drug i A study involving a medication or substance. From 18 Years to 65 Years
Countries United States
Sponsor Chase Therapeutics Corporation
Condition Depression Completed NCT01606436
This study is completed in the United States. It focuses on schizophrenia.
Schizophrenia Other From 18 Years to 65 Years
Countries United States
Sponsor Denovo Biopharma LLC
Condition Schizophrenia Active Not Recruiting NCT06245213
This study is active but not recruiting in the United States. It is testing ANAVEX3-71 for schizophrenia.
Schizophrenia Other From 18 Years to 55 Years
Countries United States
Sponsor Anavex Life Sciences Corp.
Condition Schizophrenia Completed NCT00261443
This study is completed in the United States, in France, in Brazil, .... It is testing aripiprazole (Abilify) for manic episodes in bipolarity.
Bipolarity Other Over 18 Years
Countries United States, France, Brazil, ...
Sponsor Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition Bipolarity Terminated NCT06514742
This study has public registry information in the United States, in Belgium, in Brazil, .... It is testing Aticaprant 10 mg for depression.
Depression Other From 18 Years to 64 Years
Countries United States, Belgium, Brazil, ...
Sponsor Janssen Research & Development, LLC
Condition Depression Completed NCT05550532
This study is completed in the United States, in France, in Canada, .... It is testing Aticaprant 10 Milligrams (mg) for Depression.
Depression Other From 18 Years to 74 Years
Countries United States, France, Canada, ...
Sponsor Janssen Research & Development, LLC
Condition Depression Terminated NCT05518149
This study has public registry information in the United States, in Australia, in France, .... It is testing aticaprant for depression.
Depression Other From 18 Years to 74 Years
Countries United States, Australia, France, ...
Sponsor Janssen Research & Development, LLC
Condition Depression Terminated NCT06635135
This study has public registry information in the United States, in France, in Belgium, .... It is testing aticaprant Plus an Antidepressant to Prevent Return of Depression Symptoms for depression.
Depression Other From 18 Years to 64 Years
Countries United States, France, Belgium, ...
Sponsor Janssen Research & Development, LLC
Condition Depression Completed NCT06340958
This study is completed in the United States. It is testing CLE-100 (Oral Esketamine) for depression.
Depression Other From 18 Years to 65 Years
Countries United States
Sponsor Clexio Biosciences Ltd.
Condition Depression Completed NCT04294719
This study is completed in Canada. It is testing cognitive Adaptation Training for Schizophrenia.
Schizophrenia Other Over 18 Years
Countries Canada
Sponsor Centre for Addiction and Mental Health
Condition Schizophrenia Completed NCT01940978
This study is completed in the United States. It is testing combination Therapy for ADHD.
ADHD Other From 6 Years to 12 Years
Countries United States
Sponsor Douglas Sears
Condition ADHD 
